RMR Wealth Builders Grows Stake in Oracle Co. (NYSE:ORCL)

RMR Wealth Builders lifted its stake in shares of Oracle Co. (NYSE:ORCLFree Report) by 29.7% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,277 shares of the enterprise software provider’s stock after purchasing an additional 2,122 shares during the period. RMR Wealth Builders’ holdings in Oracle were worth $1,297,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. Capital & Planning LLC grew its stake in Oracle by 0.5% during the 4th quarter. Capital & Planning LLC now owns 15,727 shares of the enterprise software provider’s stock valued at $2,621,000 after acquiring an additional 81 shares in the last quarter. Brighton Jones LLC grew its stake in Oracle by 189.3% during the 4th quarter. Brighton Jones LLC now owns 153,580 shares of the enterprise software provider’s stock valued at $25,593,000 after acquiring an additional 100,494 shares in the last quarter. Union Bancaire Privee UBP SA purchased a new stake in Oracle during the 4th quarter valued at about $51,084,000. Revolve Wealth Partners LLC grew its stake in Oracle by 8.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 5,418 shares of the enterprise software provider’s stock valued at $903,000 after acquiring an additional 404 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC grew its stake in Oracle by 13.6% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 550,414 shares of the enterprise software provider’s stock valued at $91,395,000 after acquiring an additional 65,980 shares in the last quarter. Hedge funds and other institutional investors own 42.44% of the company’s stock.

Insider Transactions at Oracle

In related news, Director Naomi O. Seligman sold 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $145.81, for a total transaction of $291,620.00. Following the sale, the director now directly owns 34,630 shares of the company’s stock, valued at $5,049,400.30. This represents a 5.46% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Leon E. Panetta sold 5,000 shares of the company’s stock in a transaction that occurred on Friday, April 11th. The stock was sold at an average price of $129.77, for a total transaction of $648,850.00. Following the sale, the director now directly owns 58,090 shares in the company, valued at approximately $7,538,339.30. The trade was a 7.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 27,366 shares of company stock worth $4,015,723. 42.20% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several brokerages recently issued reports on ORCL. Evercore ISI upped their price objective on shares of Oracle from $180.00 to $215.00 and gave the company an “outperform” rating in a research note on Thursday. UBS Group upped their price objective on shares of Oracle from $200.00 to $225.00 and gave the company a “buy” rating in a research note on Thursday. CIBC reaffirmed a “buy” rating on shares of Oracle in a research note on Monday. Cantor Fitzgerald dropped their price objective on shares of Oracle from $214.00 to $175.00 and set an “overweight” rating for the company in a research note on Tuesday, March 11th. Finally, DA Davidson upped their price objective on shares of Oracle from $140.00 to $170.00 and gave the company a “neutral” rating in a research note on Thursday. Twelve analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, Oracle has an average rating of “Moderate Buy” and a consensus target price of $192.30.

Check Out Our Latest Analysis on ORCL

Oracle Stock Performance

Shares of ORCL stock opened at $199.67 on Friday. The firm’s 50 day moving average price is $151.06 and its 200-day moving average price is $160.44. The company has a debt-to-equity ratio of 5.65, a quick ratio of 0.81 and a current ratio of 0.81. Oracle Co. has a one year low of $118.86 and a one year high of $202.49. The firm has a market cap of $558.47 billion, a P/E ratio of 48.82, a P/E/G ratio of 3.46 and a beta of 1.32.

Oracle (NYSE:ORCLGet Free Report) last issued its quarterly earnings data on Wednesday, June 11th. The enterprise software provider reported $1.70 EPS for the quarter, topping the consensus estimate of $1.64 by $0.06. Oracle had a net margin of 21.16% and a return on equity of 133.25%. The firm had revenue of $15.90 billion for the quarter, compared to analyst estimates of $15.58 billion. During the same period in the prior year, the business posted $1.63 EPS. The business’s revenue for the quarter was up 11.3% compared to the same quarter last year. As a group, equities research analysts predict that Oracle Co. will post 5 EPS for the current year.

Oracle Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, July 24th. Stockholders of record on Thursday, July 10th will be issued a $0.50 dividend. The ex-dividend date of this dividend is Thursday, July 10th. This represents a $2.00 annualized dividend and a dividend yield of 1.00%. Oracle’s dividend payout ratio is currently 46.95%.

Oracle Company Profile

(Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

See Also

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Co. (NYSE:ORCLFree Report).

Institutional Ownership by Quarter for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.